The Pershing Square Sohn Cancer Research Alliance is dedicated to playing a catalytic role in accelerating cures for cancer by enabling the pursuit of the most innovative and advanced cancer research and by facilitating collaborations between science and business.
The Prize for young investigators provides early-stage funding opportunities to New York scientists with innovative ideas in cancer research. The program surrounding the Prize is a catalyst in bridging the gap between the academic scientific community and the business community.
DANIEL BACHOVCHIN, PHD
KIVANC BIRSOY, PHD
ALBERTO CICCIA, PHD
CAMILA DOS SANTOS, PHD
BENJAMIN GREENBAUM, PHD
DAN LANDAU, MD, PHD
BENJAMIN MARTIN, PHD
The Pershing Square Sohn Cancer Research Alliance today announced the seven winners of the 2018 Pershing Square Sohn Prize for Young Investigators in Cancer Research, awarded annually to promising early career, New York City-area cancer research scientists. Recipients receive $200,000 in funding per year for up to three years, for a total of $600,000, to support bold research at a stage when traditional funding is often lacking. The awards will be presented on May 23, 2018.
On Wednesday, May 23rd, the Pershing Square Research Alliance held its Fifth Annual Prize Dinner at the Park Avenue Armory, awarding its 2018 Pershing Square Sohn Prize for Young Investigators in Cancer Research to seven exceptional groundbreaking scientists in New York City. The evening began with a panel discussion on synthetic biology, featuring Dr. Jef Boeke, Director of the Institute for Systems Genetics at NYU School of Medicine and Dr. Floyd Romesberg, Professor in the Department of Chemistry at The Scripps Research Institute. Ira Flatow, Host and Executive Producer of the popular podcast Science Friday, moderated the discussion.
Bill Ackman, Co-Founder. The Pershing Square Foundation